HIV rise sparks call to fast track antiretroviral approval

The Melbourne Declaration, delivered today at the Australasian HIV/AIDS Conference, also calls for approval of rapid testing to be expedited by the TGA and funded to make it widely available.

In July the US FDA approved Gilead’s Truvada (tenofovir/emtricitabine) for prophylactic use by people at high risk of acquiring HIV through sexual activity.